Biomarin Pharmaceutical Inc Cash Flow Statement

BMRN $77.73 1.4 1.8%

05/03/21

Balanced, Large Cap, Style Neutral

Market Cap £10.21bn

Enterprise Value £10.22bn

Revenue £1.34bn

Quality

Value

Momentum

StockRank™

To unlock Biomarin Pharmaceutical Inc's cashflow statement please upgrade your membership.

	2015	2016	2017	2018	2019	2020
Period End:	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31
Period Length:	12M	12M	12M	12M	12M	12M
Currency:	USD	USD	USD	USD	USD	USD

Net Income/Starting Line

Depreciation/Depletion
Deferred Taxes
Non-Cash Items
Unusual Items
Equity in Net Earnings (Loss)
Other Non-Cash Items
Changes in Working Capital
Accounts Receivable
Inventories
Other Assets
Payable/Accrued
Other Liabilities
Cash from Operating Activities

Capital Expenditures
Purchase of Fixed Assets
Purchase/Acquisition of Intangibles
Other Investing Cash Flow Items, Total
Acquisition of Business
Sale of Business
Sale/Maturity of Investment
Purchase of Investments
Intangible, Net
Other Investing Cash Flow
Cash from Investing Activities

Financing Cash Flow Items
Other Financing Cash Flow
Issuance (Retirement) of Stock, Net
Issuance (Retirement) of Debt, Net
Cash from Financing Activities

Foreign Exchange Effects
Net Change in Cash
Starting Cash Balance
Ending Cash Balance

Unlock Stockopedia Premium for free!

See what it can do for your stockpicking and portfolio at no expense.